Transcription of (incidence - KineretRx.com
{{id}} {{{paragraph}}}
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KINERET safely and effectively. See full prescribing information for KINERET. KINERET (anakinra) injection, for subcutaneous use Initial Approval: 2001 ----------------------------RECENT MAJOR CHANGES-------------------------- Warnings and Precautions ( ) ----------------------------INDICATIONS AND USAGE--------------------------- Kineret is an interleukin-1 receptor antagonist indicated for: Rheumatoid Arthritis (RA) Reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis, in patients 18 years of age or older who have failed 1 or more disease modifying antirheumatic drugs (DMARDs) ( ) Cryopyrin-Associated Periodic Syndromes (CAPS) Treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID) ()
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KINERET safely and effectively. See full …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}